Back to search
FDAFDA · Food and drugs·Recall number Z-0750-2024

GammaPod - Treatment Planning System-a component of the GammaPod Irradiation System. Ref: XMSGP030A09.07-0.01 Intended for use in the noninvasive stereotactic delivery of a radiation dose to a partial volume of the breast in conjunction with breast conserving treatment.

Published January 24, 2024 · Recall initiated: November 30, 2023

Summary

FDA records medical device Class II recall Z-0750-2024, published January 24, 2024 and initiated November 30, 2023. Recalling firm: Xcision Medical Systems, LLC; Status: Ongoing; Reported quantity: 4 units; Lot: 00850002615029(11)230321(21)TPS0018 (Distributed in the US) 00850002615029(11)230629(21)TPS0013 (Distributed in the US) 00850002615005(11)21H24(21)TPS0016 (Distributed in the US) 00850002615029(11)210629(21 )TPS0014 (Italy). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Wrong structures imported into the GammaPod Treatment Planning System.-system allowed an RTSS generated from a previous CT scan to be selected

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Xcision Medical Systems, LLC
Distributor
Worldwide - US Nationwide distribution in the states of MD, PA, TX and the country of Italy.
Lot
00850002615029(11)230321(21)TPS0018 (Distributed in the US) 00850002615029(11)230629(21)TPS0013 (Distributed in the US) 00850002615005(11)21H24(21)TPS0016 (Distributed in the US) 00850002615029(11)210629(21 )TPS0014 (Italy)
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was GammaPod - Treatment Planning System-a component of the GammaPod Irradiation System. Ref: XMSGP030A09.07-0.01 Intended for use in the noninvasive stereotactic delivery of a radiation dose to a partial volume of the breast in conjunction with breast conserving treatment. recalled?

Yes. FDA published recall Z-0750-2024 on January 24, 2024. Reported hazard: Wrong structures imported into the GammaPod Treatment Planning System.-system allowed an RTSS generated from a previous CT scan to be selected

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail